Publicaciones en colaboración con investigadores/as de Yale University (19)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2023

  1. CD137 (4-1BB)-Based Cancer Immunotherapy on Its 25th Anniversary

    Cancer discovery, Vol. 13, Núm. 3, pp. 552-569

2022

  1. Clinical, histological and molecular profiling of different stages of alcohol-related liver disease

    Gut, Vol. 71, Núm. 9, pp. 1856-1866

  2. Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts

    BLOOD CANCER DISCOVERY, Vol. 3, Núm. 6

2021

  1. A burned-out cd8+ t-cell subset expands in the tumor microenvironment and curbs cancer immunotherapy

    Cancer Discovery, Vol. 11, Núm. 7, pp. 1700-1715

  2. The urgent need for public health preparedness funding and support

    American Journal of Public Health, Vol. 111, Núm. 3, pp. 363-365

2020

  1. Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors

    Nature Medicine, Vol. 26, Núm. 5, pp. 688-692

  2. The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas

    Journal of Clinical Investigation, Vol. 130, Núm. 4, pp. 1879-1895

2019

  1. Expression analysis and significance of PD-1, LAG-3, and TIM-3 in human non-small cell lung cancer using spatially resolved and multiparametric single-cell analysis

    Clinical Cancer Research, Vol. 25, Núm. 15, pp. 4663-4673

  2. Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3

    Cell, Vol. 176, Núm. 1-2, pp. 334-347.e12

  3. Immunotherapy in non-small cell lung cancer: Facts and hopes

    Clinical Cancer Research, Vol. 25, Núm. 15, pp. 4592-4602

2016

  1. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome

    Nature Communications, Vol. 7

2015

  1. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

  2. Characterization of large structural genetic mosaicism in human autosomes

    American Journal of Human Genetics, Vol. 96, Núm. 3, pp. 487-497

2014

  1. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

    Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633

  2. Objective comparison of particle tracking methods

    Nature Methods, Vol. 11, Núm. 3, pp. 281-289

2012

  1. Detectable clonal mosaicism and its relationship to aging and cancer

    Nature Genetics, Vol. 44, Núm. 6, pp. 651-658

2008

  1. Frequent BRG1/SMARCA4-Inactivating mutations in human lung cancer cell lines

    Human Mutation, Vol. 29, Núm. 5, pp. 617-622